Showing 1721-1730 of 2104 results for "".
- Two in Three Cosmetic Surgery Injections in the UK Not Administered by Doctorshttps://modernaesthetics.com/news/two-in-three-cosmetic-surgery-injections-in-the-uk-nor-administered-by-doctors/2473453/Two in three neuromodulators or fillers in the UK are not administered by doctors, new research shows. For the study, researchers from UCL in London evaluated 3,000 websites to identify 1,224 independent clinics and 3,667 practitioners who performed cosmetic injections. Of the
- Venus Concept Introduces Medical Advisory Board for AI.MEhttps://modernaesthetics.com/news/venus-concept-introduces-medical-advisory-board-for-aime/2473449/The primary mission of the medical advisory board will be to provide strategic input, guidance, and clinical recommendations regarding the Company's emerging robotic technology, AI.ME, which received its first 510(k) clearance from the U.S. Food and Drug Administration (FDA) in December 2022,
- Acclaro Medical Rolls Our Rebranded UltraClear Cold Fiber Laserhttps://modernaesthetics.com/news/acclaro-medical-rolls-our-rebranded-ultraclear-cold-fiber-laser/2473448/Meet the newly re-branded UltraClear Cold Fiber Laser from Acclaro Medical. From a design perspective, rebranding encompasses an updated logo and color palette and aims to increase recognition of UltraClear's 3DIntelliPulse technology and its ability to provide optima
- L’Oréal and Verily Launch Huge Diverse Skin and Hair Health Studyhttps://modernaesthetics.com/news/loreal-and-verily-launch-huge-diverse-skin-and-hair-health-study/2473444/L’Oréal and
- Merz Aesthetics Named Sole Distributor of AccuVein’s Visualization Systemhttps://modernaesthetics.com/news/merz-aesthetics-named-sole-distributor-of-accuveins-visualization-system/2473439/Merz Aesthetics is now the sole authorized distributor of AccuVein’s vein visualization system in the U.S. aesthetics market. A limited initial AccuVein field pilot yielded positive results and significant expansion of both new customers and Merz Aesthetics portfolio ad
- CollPlant Achieves Milestone in Dermal Filler Developmenthttps://modernaesthetics.com/news/collplant-achieves-milestone-in-dermal-filler-development/2473431/CollPlant Biotechnologies hit a milestone in the development of a regenerative dermal filler, and this achievement triggers a $10 million payment from AbbVie to CollPlant. In 2021, CollPlant and AbbVie entered into an exclusive worldwide development and commercializatio
- Xeomin Performs Well in Phase 3 Studies of Upper Facial Lineshttps://modernaesthetics.com/news/xeomin-performs-well-in-phase-3-studies-of-upper-facial-lines/2473428/Two pivotal phase 3 clinical studies demonstrated the efficacy and safety of Xeomin (incobotulinumtoxinA) in the simultaneous treatment of horizontal forehead lines, glabellar frown lines, and lateral canthal lines, according to Merz Aesthetics. Merz Aesthetics will submit these data as
- Botox Cosmetic Announces the Winners of the IFundWomen Grant Programhttps://modernaesthetics.com/news/botox-cosmetic-announces-the-winners-of-the-ifundwomen-grant-program/2473427/Twenty female entrepreneurs will receive funding and mentorship through Allergan’s BOTOX Cosmetic and IFundWomen grant program. "There were so many remarkable applications that featured thoughtful business solutions," says Carrie Strom, President, Global Aller
- Body Contouring Doesn't Increase Long-term Weight Loss after Bariatric Surgery: Studyhttps://modernaesthetics.com/news/body-contouring-doesnt-increase-long-term-weight-loss-after-bariatric-surgery-study/2473421/For patients who experience massive weight loss after bariatric surgery, subsequent body contouring to remove excess skin is not itself associated with long-term weight loss, reports a
- Radiofrequency Microneedling: Optimize Your Resultshttps://modernaesthetics.com/news/radiofrequency-microneedling-optimize-your-results/2473417/For optimal results when treating patients with radiofrequency (RF) microneedling, anecdotal and personal experience guide Elizabeth L. Tanzi, MD, as there are “No significant comparison studies to date” on the